17-1830105-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1
The NM_002945.5(RPA1):c.12A>G(p.Gln4=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.746 in 1,249,336 control chromosomes in the GnomAD database, including 354,203 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.68 ( 36363 hom., cov: 31)
Exomes 𝑓: 0.76 ( 317840 hom. )
Consequence
RPA1
NM_002945.5 synonymous
NM_002945.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.23
Genes affected
RPA1 (HGNC:10289): (replication protein A1) This gene encodes the largest subunit of the heterotrimeric Replication Protein A (RPA) complex, which binds to single-stranded DNA (ssDNA), forming a nucleoprotein complex that plays an important role in DNA metabolism, being involved in DNA replication, repair, recombination, telomere maintenance, and co-ordinating the cellular response to DNA damage through activation of the ataxia telangiectasia and Rad3-related protein (ATR) kinase. The nucleoprotein complex protects the single-stranded DNA from nucleases, prevents formation of secondary structures that would interfere with repair, and co-ordinates the recruitment and departure of different genome maintenance factors. This subunit contains four oligonucleotide/oligosaccharide-binding (OB) domains, though the majority of ssDNA binding occurs in two of these domains. The heterotrimeric complex has two different modes of ssDNA binding, a low-affinity and high-affinity mode, determined by which ssDNA binding domains are utilized. The different binding modes differ in the length of DNA bound and in the proteins with which it interacts, thereby playing a role in regulating different genomic maintenance pathways. [provided by RefSeq, Sep 2017]
SMYD4 (HGNC:21067): (SET and MYND domain containing 4) Predicted to enable metal ion binding activity and methyltransferase activity. Involved in heart development. Predicted to be located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 17-1830105-A-G is Benign according to our data. Variant chr17-1830105-A-G is described in ClinVar as [Benign]. Clinvar id is 2688031.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-1.23 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.772 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPA1 | NM_002945.5 | c.12A>G | p.Gln4= | synonymous_variant | 1/17 | ENST00000254719.10 | NP_002936.1 | |
RPA1 | NM_001355121.2 | c.12A>G | p.Gln4= | synonymous_variant | 1/16 | NP_001342050.1 | ||
RPA1 | NM_001355120.2 | c.-36A>G | 5_prime_UTR_variant | 1/17 | NP_001342049.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPA1 | ENST00000254719.10 | c.12A>G | p.Gln4= | synonymous_variant | 1/17 | 1 | NM_002945.5 | ENSP00000254719 | P1 | |
RPA1 | ENST00000570451.5 | c.-36A>G | 5_prime_UTR_variant | 1/7 | 3 | ENSP00000459788 | ||||
RPA1 | ENST00000571058.5 | c.-7+205A>G | intron_variant | 4 | ENSP00000461733 | |||||
SMYD4 | ENST00000571854.5 | c.-13+488T>C | intron_variant | 4 | ENSP00000461089 |
Frequencies
GnomAD3 genomes AF: 0.681 AC: 103513AN: 151928Hom.: 36340 Cov.: 31
GnomAD3 genomes
AF:
AC:
103513
AN:
151928
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.662 AC: 14278AN: 21576Hom.: 4873 AF XY: 0.667 AC XY: 6386AN XY: 9570
GnomAD3 exomes
AF:
AC:
14278
AN:
21576
Hom.:
AF XY:
AC XY:
6386
AN XY:
9570
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.755 AC: 828869AN: 1097292Hom.: 317840 Cov.: 50 AF XY: 0.754 AC XY: 391088AN XY: 518374
GnomAD4 exome
AF:
AC:
828869
AN:
1097292
Hom.:
Cov.:
50
AF XY:
AC XY:
391088
AN XY:
518374
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.681 AC: 103584AN: 152044Hom.: 36363 Cov.: 31 AF XY: 0.671 AC XY: 49852AN XY: 74326
GnomAD4 genome
AF:
AC:
103584
AN:
152044
Hom.:
Cov.:
31
AF XY:
AC XY:
49852
AN XY:
74326
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1488
AN:
3472
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 67% of patients studied by a panel of primary immunodeficiencies. Number of patients: 64. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at